Top Markets
#1 GENIUS AI GENIUS AI +167.52%
#2 Siren Siren +17.98%
#3 WAX WAX +15.05%
#4 Cloud Cloud +11.86%
#5 GXChain GXChain +9.63%
#6 Giggle Fund Giggle Fund +9.45%
#7 Strategic Oil Supply Strategic Oil Supply +8.98%
#8 SmarDex SmarDex +8.60%
#9 ZetaChain ZetaChain +8.55%
#10 StakeStone StakeStone +7.88%
Coin of the day
GENIUS AI GENIUS AI
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Pozycja w akcjach #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Cena akcji
$137.21
Kapitalizacja rynkowa
$170.34B
Zmiana (1 dzień)
-2.76%
Zmiana (1 rok)
28.14%
Kraj
US
Handel Gilead Sciences, Inc. (GILD)

Kategoria

Healthcare
Historia stopy dywidendy dla Gilead Sciences, Inc. (GILD)
Stopa dywidendy (TTM) dla Gilead Sciences, Inc. (symbol akcji: GILD) na dzień 2024-12-31 wynosi: 3.40%
Średnia stopa dywidendy z ostatnich 5 lat: 3.43%
Historia stopy dywidendy dla Gilead Sciences, Inc. (GILD) od 2000 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
2026 (TTM) 2.20% -14.40%
2025 2.57% -24.41%
2024 3.40% -9.81%
2023 3.77% 9.59%
2022 3.44% -12.91%
2021 3.95% -16.14%
2020 4.71% 20.77%
2019 3.90% 6.56%
2018 3.66% 25.34%
2017 2.92% 14.06%
2016 2.56% 101.57%
2015 1.27% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% 0.00%
2003 0.00% 0.00%
2002 0.00% 0.00%
2001 0.00% 0.00%
2000 0.00% 0.00%
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
0.63%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
1.64%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.15%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
3.03%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
3.05%
CH